The diagnosis of relapsing polychondritis (RP) is often mistaken or delayed. In this retrospective cohort, we aimed to unveil the causes responsible for such phenomenon, to determine the associated factors, and to compare diagnosis in clinical settings with the current diagnostic criteria.
Eighty-seven RP patients followed-up by rheumatologists from January 1, 2008, to October 31, 2018, were retrospectively analyzed.
A total of 50 male and 37 female patients were included with a mean age of 45.9 ± 14.5 years. Ninety-three percent were initially admitted by non-rheumatologic specialists .Twenty-eight percent were correctly diagnosed, while 72% were misdiagnosed at the first visits, all by non-rheumatologic specialists. Patients admitted by non-rheumatologic specialists had increased odds of misdiagnosis (odds ratio [OR] = 1.3, 95% confidence interval [95% CI] 1.1–1.7, P = 0.000). Fifty-seven (65.5%) patients did not meet with Michet or Damiani criteria, with 16 (18.4%) patients diagnosed as partial RP and 41( 47.1%) patients diagnosed as limited RP.
Incorrect and delayed diagnosis of RP is common in our cohort, and insufficient awareness of the disease in non-rheumatologic specialists at least partially contributes to this. It is imperative to revise the current criteria for early diagnosis.
• Diagnosing relapsing polychondritis (RP) in early stage remains challenging after all these years, especially among non-rheumatologic specialists, indicating the importance of teaching non-rheumatologic specialists to improve their understanding of this rare disease.
• Many RP patients did not fully meet with the current criteria, suggesting that revision of the current criteria is imperative for early diagnosis of this rare disease.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, Thuermel K (2010) Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev 9(8):540–546. https://doi.org/10.1016/j.autrev.2010.02.016
Cantarini L, Vitale A, Brizi MG, Caso F, Frediani B, Punzi L, Galeazzi M, Rigante D (2014) Diagnosis and classification of relapsing polychondritis. J Autoimmun 48-49:53–59. https://doi.org/10.1016/j.jaut.2014.01.026
Longo L, Greco A, Rea A, Lo Vasco VR, De Virgilio A, De Vincentiis M (2016) Relapsing polychondritis: a clinical update. Autoimmun Rev 15(6):539–543. https://doi.org/10.1016/j.autrev.2016.02.013
Pearson CM, Kline HM, Newcomer VD (1960) Relapsing polychondritis. N Engl J Med 263:51–58. https://doi.org/10.1056/NEJM196007142630201
Kent PD, Michet CJJ, Luthra HS (2004) Relapsing polychondritis. CurrOpinRheumatol 16:56–61
Hazra N, Dregan A, Charlton J, Gulliford MC, D'Cruz DP (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford) 54(12):2181–2187. https://doi.org/10.1093/rheumatology/kev240
Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104(1):74–78
McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55(3):193–215
Damiani JM, Levine HL (1979) Relapsing polychondritis--report of ten cases. Laryngoscope 89(6 Pt 1):929–946
Zeuner M, Straub RH, Rauh G, Albert ED, Scholmerich J, Lang B (1997) Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 24(1):96–101
Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129(2):114–122
Frances C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC (2001) Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore) 80(3):173–179
Belot A, Duquesne A, Job-Deslandre C, Costedoat-Chalumeau N, Boudjemaa S, Wechsler B, Cochat P, Piette JC, Cimaz R (2010) Pediatric-onset relapsing polychondritis: case series and systematic review. J Pediatr 156(3):484–489. https://doi.org/10.1016/j.jpeds.2009.09.045
Mathew SD, Battafarano DF, Morris MJ (2012) Relapsing polychondritis in the Department of Defense population and review of the literature. Semin Arthritis Rheum 42(1):70–83. https://doi.org/10.1016/j.semarthrit.2011.12.007
Dion J, Costedoat-Chalumeau N, Sene D, Cohen-Bittan J, Leroux G, Dion C, Frances C, Piette JC (2016) Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients. Arthritis Rheum 68(12):2992–3001. https://doi.org/10.1002/art.39790
Kong KO, Vasoo S, Tay NS, Chng HH (2003) Relapsing polychondritis--an oriental case series. Singap Med J 44(4):197–200
Oka H, Yamano Y, Shimizu J, Yudoh K, Suzuki N (2014) A large-scale survey of patients with relapsing polychondritis in Japan. Inflamm Regen 34:149–156
Sharma A, Law AD, Bambery P, Sagar V, Wanchu A, Dhir V, Vijayvergiya R, Sharma K, Gupta A, Panda NK, Singh S (2014) Relapsing polychondritis: clinical presentations, disease activity and outcomes. Orphanet J Rare Dis 9:198. https://doi.org/10.1186/s13023-014-0198-1
Lin DF, Yang WQ, Zhang PP, Lv Q, Jin O, Gu JR (2016) Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature. Rheumatol Int 36(7):1003–1009. https://doi.org/10.1007/s00296-016-3449-8
Chuah TY, Lui NL (2017) Relapsing polychondritis in Singapore: a case series and review of literature. Singapore Med J 58(4):201–205. https://doi.org/10.11622/smedj.2016047
Ernst A, Rafeq S, Boiselle P, Sung A, Reddy C, Michaud G, Majid A, Herth FJF, Trentham D (2009) Relapsing polychondritis and airway involvement. Chest 135(4):1024–1030. https://doi.org/10.1378/chest.08-1180
Maimon N, Lee P, Paul N, Hwang D, Marras TK, Keshavjee S, Chan CK (2010) Tracheobronchial involvement as a sole manifestation of relapsing polychondritis. J Bronchology Interv Pulmonol 17(1):5–10. https://doi.org/10.1097/LBR.0b013e3181ca27bf
Ozbay B, Dilek FH, Yalcinkaya I, Gencer M (1998) Relapsing polychondritis. Respiration 65(3):206–207. https://doi.org/10.1159/000029262
Piette JC, Dion J, Costedoat-Chalumeau N (2018) News on relapsing polychondritis: the patient’s experience. Arthritis Care Res 70(8):1121–1123. https://doi.org/10.1002/acr.23490
Vitale A, Sota J, Rigante D, Lopalco G, Molinaro F, Messina M, Iannone F, Cantarini L (2016) Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives. Curr Rheumatol Rep 18(1):3. https://doi.org/10.1007/s11926-015-0549-5
Bachor E, Blevins NH, Karmody C, Kuhnel T (2006) Otologic manifestations of relapsing polychondritis. Review of literature and report of nine cases. Auris Nasus Larynx 33(2):135–141. https://doi.org/10.1016/j.anl.2005.11.020
Yang H, Peng L, Jian M, Qin L (2014) Clinical analysis of 15 patients with relapsing auricular polychondritis. Eur Arch Otorhinolaryngol 271(3):473–476. https://doi.org/10.1007/s00405-013-2422-3
The authors received no financial and material support.
This retrospective study was approved by the Ethic Committee of Zhengzhou University (SR-2018-LW-050) and was conducted in accordance with the Declaration of Helsinki. When analyzing the data, personal information such as name, hospital number, etc. were replaced by index numbers.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, L., Wu, T., He, Y. et al. Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort. Clin Rheumatol (2020). https://doi.org/10.1007/s10067-019-04852-3
- Clinical features
- Relapsing polychondritis